GGrantIndex
← Leaderboards

Daniel A Engel

University Of Virginia Charlottesville

Google Scholar ↗PubMed ↗ORCID ↗
$7,814,888
Attributed
$14,866,198
Total exposure
12
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2005–23
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$14,866,198 · 12

By mechanism

R01$13,517,029 · 6
R21$655,074 · 2
R41$507,596 · 2
R03$186,499 · 2

Top collaborators

Others in their field

Top investigators on “Small Molecule”

Research focus

Small MoleculeBasePathogenCellsYeastsVirusHigh Throughput ScreeningLeadLibrariesInfectionDengue VirusVaccinesWest Nile VirusInhibitor/AntagonistCulicidaeMolecularPharmaceutical ChemistryAntiviral AgentsPreventProteinsPathogenesisPathway InteractionsMemberMethodology

Grant awards (33)

High Throughput Screen for Inhibitors of Shigella Flexneri Dissemination$597,714
R01 · FY2023 · AI
High Throughput Screen for Inhibitors of Shigella Flexneri Dissemination$597,714
R01 · FY2022 · AI
High Throughput Screen for Inhibitors of Shigella Flexneri Dissemination$613,089
R01 · FY2021 · AI
Small molecule inhibitors of influenza virus nucleoprotein$300,000
R41 · FY2021 · AI · contact PI
High Throughput Screen for Inhibitors of Shigella Flexneri Dissemination$627,361
R01 · FY2020 · AI
Chemical-genetic identification of kinase pathways in Zika virus infection$80,750
R03 · FY2020 · AI · contact PI
Chemical-genetic identification of kinase pathways in Zika virus infection$80,750
R03 · FY2019 · AI · contact PI
Targeting Ebola virus for small molecule drug discovery$202,673
R21 · FY2018 · AI · contact PI
Targeting Ebola virus for small molecule drug discovery$256,642
R21 · FY2017 · AI · contact PI
Targeting dengue in the mosquito with small molecules$1,177,188
R01 · FY2016 · AI
Targeting dengue in the mosquito with small molecules$830,881
R01 · FY2015 · AI
Discovery and development of broad spectrum anti-flaviviral drugs$826,847
R01 · FY2014 · AI
Targeting dengue in the mosquito with small molecules$742,309
R01 · FY2014 · AI
Targeting dengue in the mosquito with small molecules$58,237
R01 · FY2014 · AI
Discovery and development of broad spectrum anti-flaviviral drugs$764,373
R01 · FY2013 · AI
Targeting dengue in the mosquito with small molecules$723,643
R01 · FY2013 · AI
Discovery and development of broad spectrum anti-flaviviral drugs$835,261
R01 · FY2012 · AI
Targeting dengue in the mosquito with small molecules$809,831
R01 · FY2012 · AI
Discovery and development of broad spectrum anti-flaviviral drugs$844,425
R01 · FY2011 · AI
Discovery and development of broad spectrum anti-flaviviral drugs$869,118
R01 · FY2010 · AI
Yeast Based Assays for Chemical Screens Against SARS-CoV Targets$38,500
R21 · FY2010 · NS · contact PI
Yeast Based Assays for Chemical Screens Against SARS-CoV Targets$157,259
R21 · FY2008 · NS · contact PI
High Throughput Screen for Inhibitors of Influenza NS1 Protein Function$24,999
R03 · FY2008 · MH · contact PI
Development of Yeast-Based Assays for anti-influenza drug discovery$665,597
R01 · FY2006 · AI · contact PI
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX$230,961
R01 · FY2005 · CA
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX$231,023
R01 · FY2004 · CA
Novel Tool Compounds for Chromatin Research$207,596
R41 · FY2004 · CA
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX$231,084
R01 · FY2003 · CA
CHROMATIN TARGETS FOR CANCER THERAPY$266,400
R01 · FY2002 · CA
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX$231,142
R01 · FY2002 · CA
CHROMATIN TARGETS FOR CANCER THERAPY$266,400
R01 · FY2001 · CA
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX$225,151
R01 · FY2001 · CA
CHROMATIN TARGETS FOR CANCER THERAPY$251,280
R01 · FY2000 · CA